highperformr logo

AnaptysBio's Overview

Total employees149
HeadquartersSan Diego
Founded2005

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing transformative antibody-based therapeutic products for inflammatory diseases. The company leverages its proprietary somatic hypermutation (SHM)-based antibody discovery technology platform to generate a pipeline of novel antibodies. AnaptysBio's strategy centers on targeting well-validated biological pathways in new ways to address significant unmet medical needs in autoimmune and inflammatory conditions.

Where is AnaptysBio's Headquarters?

AnaptysBio officeAnaptysBio officeAnaptysBio officeAnaptysBio office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the primary center for AnaptysBio's research and development activities, clinical operations, corporate strategy, and administrative functions.

Notable Features:

The facility includes specialized laboratory spaces essential for antibody discovery and development, alongside modern office environments. It is located in the Sorrento Valley area, known for its high concentration of biotech and technology companies.

Work Culture:

AnaptysBio cultivates a work environment driven by scientific excellence, innovation, collaboration, and a strong commitment to developing therapies that can improve patients' lives.

HQ Significance:

The San Diego headquarters provides AnaptysBio with access to a rich ecosystem of scientific talent, research institutions, and capital, crucial for a biotechnology company focused on cutting-edge therapeutic development.

Values Reflected in HQ: The headquarters, with its integrated lab and office spaces, reflects AnaptysBio's core focus on scientific research, innovation, and the efficient progression of its therapeutic candidates from discovery to clinical development.

Location:

AnaptysBio's primary operational base and headquarters are located in the United States. While the company does not maintain a widespread network of international offices, its clinical trials are often conducted globally, involving research sites and patient populations in various countries to support its drug development programs. Future commercialization efforts for its product candidates would also likely target key international markets.

Street Address:

10421 Pacific Center Court, Suite 200

City:

San Diego

State/Province:

CA

Country:

USA

AnaptysBio's Global Presence

Buying Intent Signals for AnaptysBio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AnaptysBio

As of April 2025, AnaptysBio' leadership includes:

Daniel Faga - President and Chief Executive Officer
Dennis Mulroy - Chief Financial Officer
Paul F. Lizzul, M.D., Ph.D. - Chief Medical Officer
David J. Loury - Chief Legal and Administrative Officer

Investors of AnaptysBio

AnaptysBio has been backed by several prominent investors over the years, including:

BlackRock, Inc.
The Vanguard Group, Inc.
EcoR1 Capital, LLC
Frazier Life Sciences Management, L.P.
State Street Corporation
Artisan Partners Limited Partnership

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

AnaptysBio has undergone key leadership changes in the past 12-18 months, including the appointment of a new President & CEO and a new CFO to guide its strategic objectives.

Departures

Hamza Suria, Hamza Suria stepped down from his role as President and Chief Executive Officer.
Eric Loumeau, Eric Loumeau departed from his role as Chief Financial Officer.

New Appointments:

Daniel Faga, Daniel Faga was appointed as the new President and Chief Executive Officer.
Dennis Mulroy, Dennis Mulroy was appointed as the new Chief Financial Officer.

Technology (Tech Stack) used by AnaptysBio

Discover the tools AnaptysBio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AnaptysBio Email Formats and Examples

AnaptysBio, Inc. most likely uses a common corporate email format structure. Based on patterns observed for companies of similar size and industry, the predominant format is often the first initial of the first name followed by the last name.

flast@anaptysbio.com

Format

dfaga@anaptysbio.com

Example

80%

Success rate

News and media

GlobeNewswireFebruary 27, 2024

AnaptysBio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Pipeline Updates

AnaptysBio announced its Q4 and full-year 2023 financial results, along with updates on its clinical pipeline, including progress on rosnilimab (anti-PD-1 agonist) and ANB032 (anti-BTLA modulator) programs....more

GlobeNewswireJanuary 4, 2024

AnaptysBio Announces First Patient Dosed in AZURE Phase 2b Clinical Trial of Rosnilimab in Moderate-to-Severe Atopic Dermatitis

The company reported the dosing of the first patient in its AZURE Phase 2b clinical trial, evaluating rosnilimab for the treatment of moderate-to-severe atopic dermatitis....more

GlobeNewswireNovember 1, 2023

AnaptysBio Announces Appointment of Dennis Mulroy as Chief Financial Officer

AnaptysBio appointed Dennis Mulroy as its new Chief Financial Officer, bringing significant financial and operational leadership experience within the biotechnology sector....more

GlobeNewswireAugust 2, 2023

AnaptysBio Appoints Daniel Faga as President and Chief Executive Officer

AnaptysBio announced the appointment of Daniel Faga as its President and Chief Executive Officer, and as a member of the Board of Directors, succeeding Hamza Suria....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AnaptysBio, are just a search away.